The introduction of nicotinamide to be a nicotine replacement in e-cigarette and smokeless merchandise signifies a substantial regulatory problem with the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is thought to act as a sedative at high dosages6. The claims created by Nicotine River, ECBlend, and various distributors t